EN   EN 
 
 
 EUROPEAN  
COMMISSION   
Brussels, XXX   
SANTE/11868/2017 ANNEX 
(POOL/E4/2017/11868/11868 -EN 
ANNEX.doc)  
[…](2017) XXX  draft 
ANNEX 1  
 
ANNEX  
to the  
COMMISSION IMPLEMENTING REGULATION (EU) …/...  
approving azoxystrobin as an active substance for use in biocidal products of product -
types 7, 9 and 10    
EN 2  EN ANNEX  
Common Name  IUPAC Name  
Identification Numbers  Minimum degree 
of purity of the 
active substance1 Date of 
approval  Expiry 
date of 
approval  Product 
type Specific conditions  
Azoxystrobin  IUPAC Name:  
Methyl(E) -2-{2[6-(2-
cyanophenoxy)pyrimidin -4-
yloxy]phenyl} -3-
methoxyacrylate  
 
EC No: not available  
CAS No: 131860 -33-8 965 g/kg  1st 
November  
2018  31 October 
2025  7 Azoxystrobin is considered a candidate for substitution in 
accordance with point d) of Article 10(1)  of Regulation (EU) 
No 528/2012.  
The authorisations of biocidal products are subject to the 
following condition:  
The product assessment shall pay particular  attention to the 
exposures, the risks and the efficacy linked to any uses covered 
by an application for authorisation, but not addressed in the 
Union level risk assessment of the active substance.  
 
The placing on the market of treated articles is subject to the 
following condition:  
The person responsible for the placing on the market of a 
treated article treated with or incorporating azoxystrobin shall 
ensure that the label of that treated article provides the 
information listed in the second subparagraph  of Article 58(3) 
of Regulation (EU) No  528/2012.  
9 Azoxystrobin is considered a candidate for substitution in 
accordance with point d) of Article 10(1) of Regulation (EU) 
No 528/2012.  
The authorisations of biocidal products are subject to the 
following condition:  
The product assessment shall pay particular attention to the 
exposures, the risks and the efficacy linked to any uses covered 
by an application for authorisation, but not addressed in the 
Union level risk assessment of the active subst ance.  
 
                                                 
1 The purity indicated in this column was the minimum degree of purity of the active substance evaluated . The active substance in the product placed on the market can be of 
equal or different purity if it has been proven to be technically equivalent to the evaluated active substance .  
EN 3  EN The placing on the market of treated articles is subject to the 
following condition:  
The person responsible for the placing on the market of a 
treated article treated with or incorporating azoxystrobin shall 
ensure that the label of that treated ar ticle provides the 
information listed in the second subparagraph of Article 58(3) 
of Regulation (EU) No  528/2012.  
10 Azoxystrobin is considered a candidate for substitution in 
accordance with Article 10(1)(d) of Regulation (EU) 
No 528/2012.  
The authorisations of biocidal products are subject to the 
following condition:  
The product assessment shall pay particular attention to the 
exposures, the risks and the efficacy linked to any uses covered 
by an application for authorisation, but not addressed  in the 
Union level risk assessment of the active substance.  
 
The placing on the market of treated articles is subject to the 
following condition:  
The person responsible for the placing on the market of a 
treated article treated with or incorporating azox ystrobin shall 
ensure that the label of that treated article provides the 
information listed in the second subparagraph of Article 58(3) 
of Regulation (EU) No  528/2012.